Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer

نویسندگان

چکیده

Objective Thyroid cancer (TC) is one of the fastest-growing malignant tumors. This study sought to explore mechanism immune escape mediated by receptor tyrosine kinase (KIT) in TC. Methods The expression microarray TC was acquired through GEO database, and difference analysis Kyoto encyclopedia genes genomes pathway enrichment were carried out. KIT levels cell lines (K1/SW579/BCPAP) human normal thyroid cells detected using reverse transcription quantitative polymerase chain reaction western blot analysis. transfected with overexpressed (oe)-KIT CD8+ T cocultured SW579 cells. Subsequently, proliferation, migration, invasion abilities, cytokine (interferon-γ [IFN-γ]/tumor necrosis factor-α [TNF-α]) determined colony formation assay, Transwell assays, flow cytometry, enzyme-linked immunosorbent assay. phosphorylation MAPK pathway-related protein (ERK) measured After transfection oe-KIT, treated anisomycin (an activator pathway), p-ERK/ERK programmed death-ligand 1 (PD-L1) detected. Results Differentially expressed (N = 2472) obtained from database. reduced samples lower tumor than those Overexpression inhibited Specifically, abilities lowered, proliferation level elevated, IFN-γ TNF-α increased. activation downregulated PD-L1. Conclusion suppressed blocking downregulating

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

STI 571 (formerly known as CGP 57148B) is a known inhibitor of the c-abl, bcr-abl, and platelet-derived growth-factor receptor (PDGFR) tyrosine kinases. This compound is being evaluated in clinical trials for the treatment of chronic myelogenous leukemia. We sought to extend the activity profile of STI 571 by testing its ability to inhibit the tyrosine kinase activity of c-kit, a receptor struc...

متن کامل

Receptor tyrosine kinase-mediated angiogenesis.

The endothelial cell is the essential cell type forming the inner layer of the vasculature. Two families of receptor tyrosine kinases (RTKs) are almost completely endothelial cell specific: the vascular endothelial growth factor (VEGF) receptors (VEGFR1-3) and the Tie receptors (Tie1 and Tie2). Both are key players governing the generation of blood and lymphatic vessels during embryonic develop...

متن کامل

Induced haploinsufficiency of Kit receptor tyrosine kinase impairs brain development.

Kit receptor tyrosine kinase is highly expressed in the developing mammalian brain, yet little is known about its contribution to neural cell development and function. Here we introduced a brain-specific conditional Kit loss-of-function mutation in mice and observed severe hypoplasia of the central nervous system. This was accompanied by an increase in apoptotic cell death in the early embryoni...

متن کامل

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells

c-Kit, a receptor tyrosine kinase, is involved in intracellular signaling, and the mutated form of c-Kit plays a crucial role in occurrence of some cancers. The function of c-Kit has led to the concept that inhibiting c-Kit kinase activity can be a target for cancer therapy. The promising results of inhibition of c-Kit for treatment of cancers have been observed in some cancers such as gastroin...

متن کامل

Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase.

Oncogenic Kit mutations are found in somatic gastrointestinal (GI) stromal tumors (GISTs) and mastocytosis. A mouse model for the study of constitutive activation of Kit in oncogenesis has been produced by a knock-in strategy introducing a Kit exon 11-activating mutation into the mouse genome based on a mutation found in a case of human familial GIST syndrome. Heterozygous mutant KitV558Delta/+...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Immunity, inflammation and disease

سال: 2023

ISSN: ['2050-4527']

DOI: https://doi.org/10.1002/iid3.851